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Materials and Methods

Materials
All buffering reagents, salts, and glucose were purchased from Fisher Scientific (Pittsburgh, PA). Bacto™ Casamino acids and Yeast Extract along with Tryptic Soy Agar were purchased from BD Biosciences (San Jose, CA). β-Glycerophosphate, Disodium Salt, Pentahydrate was purchased from EMD-Millipore (Darmstadt, Germany). Tryptic Soy Broth, Acetonitrile, S-trityl mercaptopropionic acid, N,N-diisopropylethylamine (DIPEA), Coomassie brilliant blue, N,N-dimethylformamide, (DMF), triisopropylsilane (TIPS) were purchased from Sigma-Aldrich (St. Louis, MO). Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) was purchased from Thermo Scientific (Rockford, IL). Standard Nα-BOC protected amino acids were purchased from Novabiochem (Läufelfingen, Switzerland). The Nα-BOC protected L-β-homo-amino acid derivatives, Nα-BOC protected β-alanine and 2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) were purchased from AnaSpec (Fremont, Ca). Trifluoroacetic acid (TFA) was purchased from Halocarbon (North Augusta, SC). Nitrocefin was purchased from TOKU-E USA (Bellingham, WA). [D 6 ]DMSO was purchased from Cambridge Isotope Laboratories (Andover, MA). All denaturing SDS-PAGE gels were purchased from Bio-Rad (Hercules, CA). 
General Methods
Analytical and semi-preparative RP-HPLC were performed on Hewlett-Packard 1100 and 1200 series instruments equipped with a C18 Vydac column (5 μm, 4.6 x 150 mm) at a flow rate of 1 mL/min or a C18 Vydac 218TP152010 column (15-20 μm; 10 x 250 mm) at a flow rate of 4 mL/min. All runs were carried out employing gradients of solvent A (0.1% TFA in water) and solvent B (90% acetonitrile in water with 0.1% TFA). For semi-preparative HPLC runs, an initial five-minute isocratic period in initial conditions was followed by a 40-minute linear gradient with increasing solvent B concentration. For most analytical HPLC runs a two-minute isocratic period in initial conditions was followed by a 20-minute linear gradient with increasing solvent B concentration. For the purified AIP analogs, analytical HPLC runs included an initial fiveminute isocratic period in 100% solvent A followed by a 20-minute linear gradient with increasing solvent B concentration. The solvent gradients are specified in each HPLC experiment when necessary. Electrospray ionization mass spectrometric analysis (ESI-MS) was performed on all AIP analogs by direct infusion on a Bruker Daltonics MicrOTOF-Q II mass spectrometer. MS/MS analysis was performed using Bruker Daltonics BioTools 3.2 software (Bruker Daltonics Inc., Billerica, MA). Coomassie stained gels were imaged on a LI-COR Odyssey Infrared Imager. The β-lactamase activation and inhibition assays were recorded on a Molecular Devices Spectramax M3 micro plate reader with absorbance measurements at 490 and 650 nm.
Bacterial Strains and Growth Conditions
The bacterial strains used have been described in a previous study. 2 These S. aureus bacterial strains are RN9222 (CA1-I), RN9367 (CA2-II) and RN9532 (CA3-III). When used for an assay, the S. aureus cells were grown in CYGP broth with shaking at 37°C. 3 Cell growth was monitored at OD540 over time. Overnight cultures in tryptic soy medium were routinely used as inocula, and the cultures were prepared from bacteria grown on tryptic soy agar plates containing erythromycin (10 μg/mL).
Synthetic Peptides
AIP analogs used in this study are listed in Table S1 . All AIP analogs were chemically synthesized using standard solid-phase approaches with 4-methylbenzhydrylamine-copoly(styrene-1% DVB) (MBHA resin) as a support. 2,4 S-trityl mercaptopropionic acid was coupled to the MBHA resin to form a thioester linker before peptide elongation using standard Boc-SPPS with in situ neutralization/HBTU activation. For the constrained and deletion AIP analogs, the cyclization reaction required ~4 hours and was monitored by analytical RP-HPLC. For the enlarged AIP analogs, the cyclization reaction was allowed to proceed overnight (~16 hours) and was monitored by analytical RP-HPLC. During the overnight cyclization reactions, the solution was brought up to 10 mM TCEP incrementally. After cyclization, the peptides were purified by semi-preparative RP-HPLC and characterized by analytical RP-HPLC and characterized by mass spectrometry (Table S1 , Figures S2 and S3 ) and NMR spectroscopy. The concentrations of stock solutions were calculated on the basis of amino acid analysis (New England Peptide, Gardner, MA), with the peptides dissolved in 50% DMSO. Frozen peptide stocks were kept in 50% DMSO after amino acid analysis and serially diluted into an assay buffer of 20% propylene glycol and phosphate buffer (100 mM, pH 5.9), which was also used for assays with cells. 5 and visualized in Sparky. 6 Two-dimensional NMR experiments characterized several enlarged AIP-I analogs. The 2-D NMR data is presented in Figure S6 .
Fluorescent anisotropy measurements
Fluorescence measurements were performed on a Fluorolog-3 instrument (HORIBA Jobin Yvon) equipped with automated dual polarizers and using a Semi-Micro Fluorometer Cell (Starna Cells) with a 10-mm path length. The measurement chamber was held at a constant temperature of 30.0°C by an Advanced Series AC200 thermostat (Thermo Scientific) connected to an Arctic series refrigerated circulating water bath In a typical experiment, 723 L of measurement buffer (20 mM HEPES, pH 7.0, 100 mM NaCl, 1 mM TCEP, 2 M BSA and 100 nM of empty nanodiscs) containing FAM-AIP-I (21 nM) was transferred to the cuvette and the fluorescent anisotropy was measured as a reference. AgrC-I nanodiscs (4.2 M, 26.8 L) were then added for a final concentration of 150 nM, and the mixture allowed to equilibrate for 3 minutes before taking the pre-competition anisotropy measurement. Finally, the competitor AIP or AIP analog (500M, 15L in 50% DMSO) was mixed in for a final concentration of 10 M and the post-competition anisotropy was measured following 3-minute incubation. Three individual competitions were performed for each compound. The averaged, reference-subtracted anisotropy measured both pre-and post-competition were plotted for each compound as shown in Figure 5 . SSA (y-axis) is calculated by subtracting the SSA value at the starting stage (free FAM-AIP-I, before the addition of AgrC-I discs) from the SSA values measured before or after competition.
Phospho-relay from AgrC-I to AgrA Assay
AgrC-I discs (4.0 M) were phosphorylated in the absence of AIP with [-32 P]-ATP (50 M) at 37°C for 120 min, and subsequently exchanged into an ATP-free reaction buffer (50 mM Tris-HCl, 15 mM HEPES-Na pH 7.8, 10mM MgCl2, 100 mM NaCl and 1 mM TCEP) using Bio-Rad Micro Bio-Spin™ P-6 Gel Columns. The stock was equally divided into four portions, to which was added 10 M (final concentration) D5A AIP-I, AIP-I, AIP-II or vehicle (DMSO). These pre-phosphorylated AgrC-I stocks (50 L) were mixed with AgrA protein (10 L from a 50 M stock in 50 mM Tris-HCl pH 8.0, 100 mM NaCl , 5 mM TCEP in 20% (v/v) glycerol) to initiate the phospho-relay. The AgrA buffer was used to mix with AgrC-I samples in mock reactions. All reactions were incubated at 30°C from which 10-L samples were withdrawn at indicated time points, mixed with 4x SDS sample buffer and chilled on ice. All samples were resolved on a 15% Tris-HCl SDS-polyacrylamide gel and detected through autoradiography as describe in the Autophosphorylation Assay secton of the Experimental Section. The data is presented in Figure S9 . 19) . All of the activation and inhibition assays looked similar depending upon the AIP analogs biological activity. Hydrolysis of nitrocefin is indicated by a color shift of yellow to red. (Figure  4) , which was then normalized to zero. Using this average, a CSD standard deviation (σ) was calculated and plotted as dotted lines equal to ± 2σ. If a residue--specific CSD lies outside the ± 2σ zone, it is considered a significant CSD within that AIP--I analog. A) Met, B) Ile, C) Phe, D) Cys, and E) Tyr, which is provided for further perspective, since the tail residues show significantly smaller CSD values. 
